Sign in

CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company

Dianthus Therapeutics, Inc. /DE/

Sign in to watch
Ticker
DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
929-999-4055
Business address
7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
Former names
Magenta Therapeutics, Inc.
  1. SC 13D/A Stake Beneficial Ownership Report
  2. SC 13G Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G Stake Amended Statement of Ownership
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. SC 13G Stake Amended Statement of Ownership
  9. RW Other RW
  10. 424B5 Offering Prospectus
  11. SC 13G Stake Amended Statement of Ownership
  12. 424B3 Offering Prospectus
  13. EFFECT Other Notice of Effectiveness
  14. EFFECT Other Notice of Effectiveness
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. UPLOAD Other SEC-generated Letter
  18. UPLOAD Other SEC-generated Letter
  19. 4 Other disposition Director disposed of 62,146 shares (other)
  20. S-3 Offering Registration Statement

Page 9 of 33 · 659 filings